Growth Metrics

Resmed (RMD) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $285.9 million.

  • Resmed's Long-Term Deferred Tax rose 3650.7% to $285.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $285.9 million, marking a year-over-year increase of 3650.7%. This contributed to the annual value of $253.1 million for FY2025, which is 2434.06% up from last year.
  • Resmed's Long-Term Deferred Tax amounted to $285.9 million in Q4 2025, which was up 3650.7% from $275.9 million recorded in Q3 2025.
  • Resmed's 5-year Long-Term Deferred Tax high stood at $285.9 million for Q4 2025, and its period low was $49.9 million during Q1 2021.
  • In the last 5 years, Resmed's Long-Term Deferred Tax had a median value of $135.6 million in 2023 and averaged $147.8 million.
  • In the last 5 years, Resmed's Long-Term Deferred Tax soared by 9457.93% in 2021 and then dropped by 19.77% in 2022.
  • Over the past 5 years, Resmed's Long-Term Deferred Tax (Quarter) stood at $74.7 million in 2021, then increased by 14.88% to $85.8 million in 2022, then soared by 81.8% to $156.0 million in 2023, then soared by 34.3% to $209.4 million in 2024, then skyrocketed by 36.51% to $285.9 million in 2025.
  • Its Long-Term Deferred Tax was $285.9 million in Q4 2025, compared to $275.9 million in Q3 2025 and $253.1 million in Q2 2025.